Be in the Know: An Opportunity for Medical Device Companies: CE Marking and Coming EU Regulatory Changes

Publications
Written By Guest User

OBIO's Dr. Klaus Fiebig, VP Strategic Programs, recently attended an insightful workshop on the upcoming regulatory changes affecting the CE mark. Obtaining the CE mark is a "mandatory hurdle" to access the $56B EU market, and the new regulatory changes present an opportunity for medical device companies.

Should these changes adjust your CE mark milestones? Read the Klaus' analysis and decide.

Download the blog here

Guest User
Previous

Be in the Know with OBIO: Getting Your Foot in the Door with Pharma - Alexion Day Reflections
Next

Raising Capital in the Digital Health Industry: Lessons from FCA Venture Partners